Olema Oncology to Participate in Upcoming Investor Conferences
May 09, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, May…
Ultragenyx to Participate at Bank of Americas 2025 Healthcare Conference
May 07, 2025 17:00 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, May 07, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO)…
Minaris Advanced Therapies launches as the leading global partner dedicated to cell therapy development, manufacturing, and testing
New company unveiled at the annual ISCT conference in New Orleans combines…
iBios First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical Model
May 05, 2025 08:00 ET | Source: iBio, Inc. Activin E antibody…
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
Court will not hear cross-claim that challenges the PH-ILD indication in the…
Xilio Therapeutics Announces Inducement Grant UnderNasdaq Listing Rule 5635(c)(4)
May 02, 2025 16:30 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass.,…
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
ALPHARETTA, Ga., May 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD),…
Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
April 26, 2025 10:00 ET | Source: Protara Therapeutics TARA-002 demonstrates 100%…
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025 13:10 ET | Source: Starton Therapeutics Inc. PARAMUS, N.J.,…